News of Note—Prevnar 13, leprosy vaccine and more

In this week's news of note, MSF is challenging a Prevnar 13 patent.

Here is some other vaccine news of note for this week.

> Médecins Sans Frontières is moving to block Pfizer's new Prevnar 13 patent in India. Release

> The Infectious Disease Research Institute and American Leprosy Missions started a phase 1 study for the first vaccine specifically targeting leprosy. Release

> CSL, which owns flu vaccine player Seqirus, changed its executive pay policies. Sydney Morning Herald story